ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Characterization of a Pyroptosis-Related Signature for Prognosis Prediction and Immune Microenvironment Infiltration in Prostate Cancer

Zhang, Guian; Luo, Yong; Dong, Weimin; Zhong, Weide*广州医学院; 南方医科大学; 1; 5
Computational and Mathematical Methods in Medicine2022-4-27DOI: 10.1155/2022/8233840
4被引8阅读
引用收藏
分享

摘要

This study was aimed at constructing a pyroptosis-related signature for prostate cancer (PCa) and elucidating the prognosis and immune landscape and the sensitivity of immune checkpoint blockade (ICB) therapy in signature-define subgroups of PCa. We identified 22 differentially expressed pyroptosis-related genes in PCa from The Cancer Genome Atlas (TCGA) database. The pyroptosis-related genes could divide PCa patients into two clusters with differences in survival. Seven genes were determined to construct a signature that was confirmed by qRT-PCR to be closely associated with the biological characteristics of malignant PCa. The signature could effectively and independently predict the biochemical recurrence (BCR) of PCa, which was validated in the GSE116918 and GSE21034. We found that patients in the high-risk group were more prone to BCR and closely associated with high-grade and advanced-stage disease progression. Outperforming clinical characteristics and nine published articles, our signature demonstrated excellent predictive performance. The patients in the low-risk group were strongly related to the high infiltration of various immune cells including CD8+ T cells and plasma B cells. Furthermore, the high-risk group with higher TMB levels and expression of immune checkpoints was more likely to benefit from immune checkpoint therapy such as PD-1 and CTLA-4 inhibitors. The sensitivity to chemotherapy, endocrine, and targeted therapy showed significant differences in the two risk groups. Our signature was a novel therapeutic strategy to distinguish the prognosis and guide treatment strategies.

学科与关键词

关键词
GENE SIGNATURECELL-DEATHBIOCHEMICAL RECURRENCEPROGRESSIONVALIDATIONMECHANISMSTHERAPYPD-L1
相关
加载中…
  • Development and validation of novel inflammatory response-related gene signature to predict prostate cancer recurrence and response to immune checkpoint therapy
    Luo, Yong; Liu, Xiaopeng; Lin, Jingbo*; Zhong, Weide*; Chen, Qingbiao*Mathematical Biosciences and Engineering, 2022, 19(11): 11345-11366.
  • An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer
    Zhang, Guian; Luo, Yong*International Journal of General Medicine, 2021, 14: 9031-9049.被引 1
  • Identification of ZDHHC1 as a Pyroptosis Inducer and Potential Target in the Establishment of Pyroptosis-Related Signature in Localized Prostate Cancer
    Luo, Cheng-Gong; Gui, Cheng-Peng; Huang, Gao-Wei; Chen, Jin-Long; Li, Jia-Ying; Li, Peng-Ju; Xu, Quan-Hui; Wang, Ying-Han; Zhu, Jiang-Quan; Liang, Hui; Wang, Zhu; Deng, Qiong; Cao, Jia-Zheng; Luo, Jun-Hang*; Lu, Jun*; Chen, Wei*Oxidative Medicine and Cellular Longevity, 2022, 2022: 5925817.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Computational and Mathematical Methods in Medicine
发表日期
2022-04-27
卷期
第 2022 卷
页码
8233840
DOI
10.1155/2022/8233840
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82072813, 81571427]; Guangzhou Municipal Science and Technology Project [201803040001]

作者

  • Z

    Zhang, Guian (第一作者)

    1

  • L

    Luo, Yong

    2 · southern med univ

查看全部 4 位作者收起作者
  • D

    Dong, Weimin

    5 · guangzhou med univ

  • Z

    Zhong, Weide (通讯)

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417